Recall Register

Food, drugs, devices › Integrity Implants Inc.

Device recall: FlareHawk Interbody Fusion System (previously XCage Interbody Fusion System) Instructions for Use (IFU's) only. Product

FDA enforcement event 81247 · Class II · initiated 27 Feb 2018 · status Terminated · terminated 6 May 2019

DeviceVoluntary: Firm initiated1 product recordCooper City, FL

FDA enforcement event 81247 is a device recall by Integrity Implants Inc. of Cooper City, FL, initiated 27 Feb 2018 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 92% of the 1,074 device enforcement events initiated in 2018 carry the same class.

Status: Terminated, terminated 6 May 2019. Initiation: voluntary: firm initiated. Integrity Implants Inc. has 4 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Integrity Implants Inc., Cooper City, FL.

Reason for recall

"Recently Integrity Implants uncovered a discrepancy in the cleaning parameters in several of their labeling material. The firm is initiating the field correction to ensure that updated information is provided to all accounts."

Distribution

"US nationwide in the states of AZ, CA, CO, DC, FL, GA, IA, IL, IN, KS, LA, MA, MS, NJ, NV, NY, OH, OR, PA, RI, SC, TX, and VA."

Product records

Recall numberProductQuantityClassStatusReport date
Z-0405-2019FlareHawk Interbody Fusion System (previously XCage Interbody Fusion System) Instructions for Use (IFU's) only. Product Usage: Indicated for spinal intervertebral body fusion with autogenous bone graft in skeletally mature individuals with degenerative disc disease.75 setsClass IITerminated14 Nov 2018

Context

92%of 2018 device events are Class II1,074 events that year
1product record in this eventfirm median: 1
4events on this register for the firm

Other enforcement events for Integrity Implants Inc.

InitiatedProduct (first record)TypeClassRecords
20 Dec 2024Brand Name: N/A Product Name: Repeater Bone Tamp Model/Catalog Number: ASY-00132 Software Version: N/A Product DescriptiDeviceClass II1
3 Aug 2022LineSider Spinal System pedicle screws, 5.5/6.0mm, Non-mod Standard 7.1mm - Dual Lead, Non-cannulated. Model Number LS-NDeviceClass II1
27 Jan 2022LineSider Spinal System 5.5/6.0mm, Non-mod Standard 7.1mm - Dual Lead, Non-cannulated. Thoracolumbosacral pedicle screw DeviceClass II3

All 4 events for Integrity Implants Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Recently Integrity Implants uncovered a discrepancy in the cleaning parameters in several of their labeling material. The firm is initiating the field correction to ensure that updated information is provided to all accounts."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US nationwide in the states of AZ, CA, CO, DC, FL, GA, IA, IL, IN, KS, LA, MA, MS, NJ, NV, NY, OH, OR, PA, RI, SC, TX, and VA."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 6 May 2019. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.